Cargando…
The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data
Hyperuricemia causes gout and has also been associated with metabolic syndrome and cardiovascular disease. Uric acid‐lowering drugs (ULDs) are used to reduce uric acid levels for the treatment of hyperuricemia and gout. However, there is a lack of robust and real‐world data on the history and treatm...
Autores principales: | Akari, Seigo, Nakamura, Takashi, Furusawa, Kenichi, Miyazaki, Yuichi, Kario, Kazuomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380143/ https://www.ncbi.nlm.nih.gov/pubmed/35818841 http://dx.doi.org/10.1111/jch.14539 |
Ejemplares similares
-
Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
por: Zhang, Di
Publicado: (2022) -
Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
por: Kario, Kazuomi, et al.
Publicado: (2021) -
Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009) -
Susceptibility genes of hyperuricemia and gout
por: Nian, Yue-Li, et al.
Publicado: (2022) -
Studies of Health Insurance Claims Data in Japan: A Scoping Review
por: Suto, Maiko, et al.
Publicado: (2023)